July 1, 2018
New study shows brain activity measured by QEEG can help predict which children may or may not respond to medications for ADHD
Resources
Latest News and Science
February 19, 2018
Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication-free technique, has long-lasting effects, according to a recent study published in the medical journal European Child & Adolescent Psychiatry.
February 6, 2018
Researchers find cost of rTMS treatment to be more cost-effective as compared to antidepressant medication trials, factoring in financial commitment and quality of life post treatment.
November 15, 2017
New study shows that magnetic brain stimulation (TMS) combined with concurrent psychotherapy is more effective than either technique alone with 66% of research subjects with Depression responding well in an average of 21 session. 65% of the group achieved long-term benefit.
October 26, 2017
Members of the Royal Australian and New Zealand College of Psychiatry are putting forward a new submission to have TMS subsidized under Australia’s public health fund, Medicare.
September 21, 2017
neuroCare’s brand of evidence-based and sustainable therapies for ADHD, Depression & OCD, is now available in Melbourne as the company joins with the Listen And Learn Centre in Balwyn.
August 30, 2017
neuroCare was the proud sponsor of the ADHD Heroes team for the 2017 City2Surf event in Sydney, entered by ‘ADDults with ADHD,’ a charity dedicated to improving the lives of adults and families dealing with ADHD.
March 15, 2017
A study by neuroCare's researchers in The Netherlands has looked at the effects of TMS on patients with treatment resistant OCD, finding that 55% of patients responded to treatment and were more likely to respond if they had also addressed a sleep issue.
